Stage II Gastric Cancer AJCC v7
generalStage IIA includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)
33
Centers
33
Active Trials
—
Cancer Funding
Top Centers for Stage II Gastric Cancer AJCC v7(33)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.5 |
| 2 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.5 |
| 3 | NCI Comprehensive Active Research Program | 51.5 |
| 4 | NCI Comprehensive Active Research Program | 51.5 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.5 |
| 6 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 51.5 |
| 7 | NCI Comprehensive Active Research Program | 51.5 |
| 8 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.5 |
| 9 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.5 |
| 10 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.5 |
| 11 | NCI Clinical Active Research Program | 51.5 |
| 12 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.5 |
| 13 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.5 |
| 14 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 51.5 |
| 15 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.5 |
| 16 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.5 |
| 17 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 51.5 |
| 18 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.5 |
| 19 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.5 |
| 20 | Boston University Cancer CenterBoston, MA Active Research Program | 51.5 |
| 21 | Active Research Program | 51.5 |
| 22 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.5 |
| 23 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 51.5 |
| 24 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.5 |
| 25 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.5 |
| 26 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.5 |
| 27 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 51.5 |
| 28 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 51.5 |
| 29 | Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program | 51.5 |
| 30 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 51.5 |
| 31 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 51.5 |
| 32 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.5 |
| 33 | Active Research Program | 51.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →